Simultaneous determination of DTPA,EDTA, and NTA by UV–visible spectrometry and HPLC

In this study, UV–visible spectrophotometry (UV–Vis) and high-performance liquid chromatography (HPLC) were used for simultaneous analysis of chelating agents diethylenetriamine pentaacetic acid (DTPA), ethylenediamine tetraacetic acid (EDTA), and nitrilotriacetic acid (NTA), as their metal chelates in dishwashing detergents, natural waters, and pulp mill water. The total amounts of the chelating agents in dishwashing detergents were verified by potentiometric titration with Fe(III) solution. Nickel(II) chelates were determined by UV–Vis and iron(III)chelates by HPLC and titration. Recoveries of DTPA, EDTA, and NTA from a standard mixture of analytes by UV–Vis were 107±7, 101±12 and 94±13%, respectively, and the recovery of the total amount of complexing agents was 99±4%. The limits of detection for DTPA, EDTA, and NTA were 667, 324, and 739 mol L^–1, respectively. In HPLC measurements the optimized mobile phase contained 0.03 mol L^–1 sodium acetate, 0.002 mol L^–1 tetrabutylammonium bromide, and 5% methanol at pH 3.15 and the detection was by UV–Vis detection at 254 nm. All three complexing agents could be separated from each other in a simultaneous analysis in less than 5 min. The limits of detection were 0.34, 0.27, and 0.62 mol L^–1 for DTPA, EDTA, and NTA, respectively. The total amounts of the analytes measured in the dishwashing detergents by the three techniques were found to be highly comparable (ANOVA: F=0.04, P=0.96). R² values were 0.99 for EDTA, 0.99 for NTA, and 0.99 for all the results when UV–Vis and HPLC determinations were compared using regression lines. The UV–Vis and HPLC methods were proved to be viable also for analyses of natural and pulp mill waters. The absence of matrix interferences was verified by the standard addition technique.     

Interaction of flavonoids,the naturally occurring antioxidants with different media: A UV–visible spectroscopic study

Quantitative parameters for interaction of flavonoids—the naturally occurring antioxidants, with solvents and surfactants are determined using UV–visible absorption spectroscopy. The availability of flavonoids; kaempferol, apigenin, kaempferide and rhamnetin in micelles of sodium dodecyl sulfate (SDS) is reflected in terms of partition coefficient, K_c. Thermodynamic calculations show that the process of transfer of flavonoid molecules to anionic micelles of SDS is energy efficient. A distortion in flavonoid's morphology occurs in case of kaempferol and apigenin in surfactant and water, exhibited in terms of a new band in the UV region of electronic spectra of these flavonoids. The partition coefficients of structurally related flavonoids are correlated with their antioxidant activities.     

Advances in analytical toxicology: the current role of liquid chromatography–mass spectrometry in drug quantification in blood and oral fluid

This paper reviews procedures for quantification of drugs in the biosamples blood, plasma, serum, or oral fluid (saliva, etc.) using liquid chromatography coupled with single-stage or tandem mass spectrometry (LC–MS, LC–MS–MS). Such procedures are important prerequisites for competent toxicological judgment and consultation in clinical and forensic toxicology. They cover blood (plasma, serum) analysis of amphetamines and related designer drugs, anesthetics, anticonvulsants, benzodiazepines, opioids, serotonergic drugs, tricyclic antidepressants, neuroleptics, antihistamines, beta-blockers, muscle relaxants, and sulfonylurea-type antidiabetics, and oral fluid analysis of amphetamines and related designer drugs, cocaine, benzoylecgonine, codeine, morphine, enantiomers of methadone and its main metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), the nicotine metabolites cotinine and hydroxycotinine, and finally risperidone and its metabolite 9-hydroxyrisperidone. Basic information on the procedures is given in two tables and an example of quantification is illustrated in two figures. The pros and cons of such LC–MS procedures including sample work-up and ion suppression effects are critically discussed.     

Simultaneous quantification of Pacific ciguatoxins in fish blood using liquid chromatography–tandem mass spectrometry

Ciguatera fish poisoning (CFP) is a food intoxication caused by exposure to ciguatoxins (CTXs) in coral reef fish. Rapid analytical methods have been developed recently to quantify Pacific-CTX-1 (P-CTX-1) in fish muscle, but it is destructive and can cause harm to valuable live coral reef fish. Also fish muscle extract was complex making CTX quantification challenging. Not only P-CTX-1, but also P-CTX-2 and P-CTX-3 could be present in fish, contributing to ciguatoxicity. Therefore, an analytical method for simultaneous quantification of P-CTX-1, P-CTX-2, and P-CTX-3 in whole blood of marketed coral reef fish using sonication, solid-phase extraction (SPE), and liquid chromatography tandem mass spectrometry (LC-MS/MS) was developed. The optimized method gave acceptable recoveries of P-CTXs (74–103 %) in fish blood. Matrix effects (6–26 %) in blood extracts were found to be significantly reduced compared with those in muscle extracts (suppressed by 34–75 % as reported in other studies), thereby minimizing potential for false negative results. The target P-CTXs were detectable in whole blood from four coral reef fish species collected in a CFP-endemic region. Similar trends in total P-CTX levels and patterns of P-CTX composition profiles in blood and muscle of these fish were observed, suggesting a relationship between blood and muscle levels of P-CTXs. This optimized method provides an essential tool for studies of P-CTX pharmacokinetics and pharmacodynamics in fish, which are needed for establishing the use of fish blood as a reliable sample for the assessment and control of CFP.

Correction of discrepancies in dioxin quantification between immunoassay and gas chromatography–high-resolution mass spectrometry

Due to the toxicity of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans (PCDD/F), efforts are made to quantify their emission into the environment. Typically, this quantification is done using gas chromatography–high-resolution mass spectrometry (GC–HRMS). However, GC–HRMS is extremely expensive and time consuming, and GC–HRMS facilities are overly requested. In order to decrease the workload on GC–HRMS, another alternative is to use an enzyme-linked immunosorbent assay (ELISA) as a semi-quantitative screening tool. One problem of this solution is that ELISA measures the total PCDD/F content of a sample differently than GC–HRMS; a disparity exists between the two techniques. This paper introduces a congener correction factor that adjusts ELISA results for this incompatibility. The importance of the correction factor is explored by examining the congener profiles of 27 different dioxin sources. The congener profiles for many of these sources are such that large incompatibilities in predicted PCDD/F content would likely exist between uncorrected ELISA and GC–HRMS. The effect that the correction factor has on the correlation between ELISA and GC–HRMS for samples from a test site with dioxin-contaminated soils was also examined. The congener profile at this site was such that the inconsistencies between uncorrected ELISA and GC–HRMS results were relatively small. However, application of the congener correction factor still improved the correlation between ELISA and GC–HRMS by 11% when using sample-specific correction factors and by 5% when using an average site-wide correction factor. The findings of this paper suggest that application of the correction factor is necessary to remove incompatibilities between ELISA and GC–HRMS—particularly when the congener profile at a site would lead to incompatibilities that are large.     

Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography–mass spectrometry

Peptide quantification by liquid chromatography–mass spectrometry (LC–MS) combines the high resolving power of reversed-phase (RP) chromatography with the excellent selectivity and sensitivity of mass spectrometric detection. On the basis of comprehensive practical experience in the analysis of small molecules, pharmaceutical research is developing technologies for analysis of a growing number of peptidic drug candidates. This article is a detailed review of procedures based on LC–MS techniques for quantitative determination of peptides. With the focus on pharmaceutical applications several technologies for sample preparation, various aspects of peptide chromatography, important characteristics of ESI–MS, selectivity of MS-detection modes, the large variability of internal standards, and modern instrumentation are discussed. The demand for reliable, robust, sensitive, and accurate methods is discussed using numerous examples from the literature, complemented by experiments and results from our laboratory.     

Identification and quantification of glucosinolates in rapeseed using liquid chromatography–ion trap mass spectrometry

A rapid and sensitive method for the speciation and quantification of glucosinolates in rapeseed is described. The method combines liquid chromatography (LC) with ion trap mass spectrometry (ITMS) detection. Electrospray ionization (ESI) has been chosen as the ionization technique for the on-line coupling of LC with ITMS. Glucosinolates are extracted from different rapeseeds with MeOH and the extracts are cleaned-up by solid phase extraction with Florisil cartridges. Aqueous extracts are injected into LC system coupled to an ITMS, leading to accurately quantify eight of the most important glucosinolates in rapeseed, by MS² mode and confirming their structure by MS³ acquisition. All the glucosinolates found in rapeseeds provide good signals corresponding to the deprotonated precursor ion [M-H]⁻. The method is reliable and reproducible, and detection limits range from 0.5 nmol g⁻¹ to 3.7 nmol g⁻¹ when 200 mg of dried seeds of certified reference material are analyzed. Within-day and between-day RSD percentages range between 2.4–14.1% and 3.9–16.9%, respectively. The LC-ESI-ITMS-MS method described here allows for a rapid assessment of these metabolites in rapeseed without a desulfatation step. The overall process has been successfully applied to identify and quantify glucosinolates in rapeseed samples.     

Feasibility study: fast liquid chromatography–mass spectrometry for the quantification of aspartic acid in an aspartate drug

We have studied the feasibility of fast high-performance liquid chromatography coupled to electrospray ionization mass spectrometry in the selected ion monitoring mode for the quantitative determination of aspartic acid in an aspartate drug. Internal standardization was required, but mass spectrometric detection allowed for very short retention times of approximately 0.5 min for the analyte and the internal standard without chromatographic separation. The analytical system was found stable, as demonstrated by multiple injections giving a coefficient of variation of 4% for the peak area ratio of aspartic acid and glutamic acid. Calibrations were linear between 0.5 ng and 150 ng aspartic acid injected, with accuracies between 99.8% and 102% found for the back-calculated amounts. Investigation of several drug batches gave reasonable results. Therefore, the method appeared feasible for the determination of aspartic acid in an aspartate drug from 0.3 wt% to 100 wt% aspartic acid.Abbreviations CV coefficient of variation - ESI electrospray ionization - HPLC high-performance liquid chromatography - HSGC headspace gas chromatography - KaFi Karl Fischer titration - MS mass spectrometry - MSD mass-selective detector - % m/m percentage by weight - PAR peak area ratio - r² coefficient of determination - RP reversed-phase - SIM selected ion monitoringThis work was originally presented as a poster at the Conference of the German Society for Mass Spectrometry, 9–12 March 2003, in Münster, Germany     

Liquid chromatography–tandem mass spectrometry analysis of neonicotinoid pesticides and 6-chloronicotinic acid in environmental water with direct aqueous injection

An efficient, high throughput and cost-effective direct aqueous injection approach for the analysis of neonicotinoid pesticides and a common metabolite in environmental water has been described here. The method determines eight neonicotinoid pesticides (acetamiprid, clothianidin, dinotefuran, flonicamid, imidacloprid, nitenpyram, thiacloprid, thiamethoxam) and 6-chloronicotinic acid (a common metabolite of the first generation neonicotinoids, acetamiprid, imidacloprid, nitenpyram and thiacloprid) without any sample enrichment/cleanup steps. The method detection limits are 2–8 ng/L for the neonicotinoids and 93 ng/L for 6-chloronicotinic acid. The performance of the QTRAP^®5500 mass spectrometer was compared against a 4000QTRAP^®, and a QTRAP^®6500, to provide insights for future method transfer among different generations of instrumentations. Critical mass spectrometric parameters such as collision energy were quite consistent among the three instruments evaluated. However, increased chemical background levels for some target compounds on the more sensitive instruments were observed. The application of differential ion mobility spectrometry combined with tandem mass spectrometry was demonstrated to have great potential in reducing chemical background and/or isobaric interferences inherited in sample matrices. This ISO 17025 accredited method was employed to quantitate neonicotinoids in Ontario stream water samples. Good correlation for analytical results of this direct aqueous injection approach and a previously published solid phase extraction approach warrant high confidence in data quality.     

Electrochemically active–inactive switching molecular beacon for direct detection of DNA in homogenous solution

We report a new kind of electrochemical molecular beacon, termed “electrochemically active–inactive switching molecular beacon”, for direct detection of DNA in homogenous solution. The electrochemical molecular beacon consists of a stable stem-loop oligonucleotide carrying two carminic acid moieties (acting as electrochemical reporter) attached at its termini. In a close form, the electrochemical signal is quenched because two carminic acid moieties are close enough to associate into dimer. In the presence of the complementary DNA target, the electrochemical molecular beacon undergoes a conformational transformation from closed (hairpin) to open (linear) structure, which is associated with an increase in electrochemical signal. We found that the electrochemical molecular beacon is as effective as conventional molecular beacon in signaling the presence of complementary target and discriminating targets that differ by a single nucleotide. The proposed electrochemical molecular beacon has a great potential for investigating the interactions of DNA-protein and developing electrochemical real-time polymerase chain reaction.     

Speciation of chromium in water samples using dispersive liquid–liquid microextraction and flame atomic absorption spectrometry

A novel method for preconcentration is described for chromium speciation at microgram per liter to sub-microgram per liter levels. It is based on selective complex formation of both Cr(VI) and Cr(III) followed by dispersive liquid–liquid microextraction and determination by microsample introduction-flame atomic absorption spectrometry. Effects influencing complex formation and extraction (such as pH, temperature, time, solvent, salinity and the amount of chelating agent) have been optimized. Enrichment factors up to 275 and 262 were obtained for Cr(VI) and total Cr, respectively. The calibration graph is linear from 0.3 to 20 µg L^?1, and detection limits are 0.07 and 0.08 µg L^?1 for Cr(VI) and total Cr, respectively. Relative standard deviations (RSDs) were obtained to be 2.0% for Cr(VI) and 2.6% for total Cr (n?=?7).     

Adsorption/desorption of acid violet-7 onto magnetic MnO2 prior to its quantification by UV–visible spectroscopy: optimized by fractional factorial design

Research on Chemical Intermediates - A highly efficient magnetic adsorbent is presented to preconcentrate acid violet-7 (AV-7) prior quantifying by UV–visible spectroscopy...     

Direct quantification of intact FIM in monkey plasma using a selective chromatography–tandem mass spectrometry method: Application in a pharmacokinetic study

FIM protein, which consists of 155 amino acids, was developed as a novel GLP-1 analog to reduce blood glucose, and pharmacodynamic results showed that it had a certain effect when used in treating Alzheimer's disease. The molecular weight of FIM is 16,304 Da. In theory, the concentration of FIM in biological samples should be determined by the ligand binding assay method or indirectly quantified using LC–MS/MS instrumentation. However, the above methods are complex and time-consuming. In this study, we successfully developed a simpler LC–MS/MS method for directly quantifying the intact FIM protein in monkey plasma for the first time. The chromatographic separation of FIM was achieved using an InertSustain Bio C₁₈ column with a mobile phase of acetonitrile containing 0.1% formic acid (A)–water containing 0.1% formic acid (B) at a flow rate of 0.3 ml/min. Good linearity was observed in the concentration range of 5–500 ng/ml (r² > 0.99). The intra- and inter-day precisions (expressed as relative standard deviation, RSD) of FIM were 2.30–12.8 and 7.30–13.2%, respectively. The intra- and inter-day accuracies (expressed as a relative error, RE) were −12.7–6.55 and − 10.1–0.892%, respectively. This method was successfully applied for a pharmacokinetic study of the FIM protein in four monkeys after subcutaneous administration.     

Rapid analysis of caffeine in various coffee samples employing direct analysis in real-time ionization–high-resolution mass spectrometry

The development and use of a fast method employing a direct analysis in real time (DART) ion source coupled to high-resolution time-of-flight mass spectrometry (TOFMS) for the quantitative analysis of caffeine in various coffee samples has been demonstrated in this study. A simple sample extraction procedure employing hot water was followed by direct, high-throughput (<1 min per run) examination of the extracts spread on a glass rod under optimized conditions of ambient mass spectrometry, without any prior chromatographic separation. For quantification of caffeine using DART-TOFMS, an external calibration was used. Isotopically labeled caffeine was used to compensate for the variations of the ion intensities of caffeine signal. Recoveries of the DART-TOFMS method were 97% for instant coffee at the spiking levels of 20 and 60 mg/g, respectively, while for roasted ground coffee, the obtained values were 106% and 107% at the spiking levels of 10 and 30 mg/g, respectively. The repeatability of the whole analytical procedure (expressed as relative standard deviation, RSD, %) was <5% for all tested spiking levels and matrices. Since the linearity range of the method was relatively narrow (two orders of magnitude), an optimization of sample dilution prior the DART-TOFMS measurement to avoid saturation of the detector was needed.     

Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry

The first method for quantifying cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry (LC–MS/MS) was developed and validated. Solid-phase extraction followed protein precipitation with acetonitrile. High-performance liquid chromatography separation was achieved in 16 min via gradient elution. Electrospray ionization was utilized for cannabinoid detection; both positive (Δ⁹-tetrahydrocannabinol [THC] and cannabinol [CBN]) and negative (11-hydroxy-THC [11-OH-THC], 11-nor-9-carboxy-THC [THCCOOH], cannabidiol [CBD], THC-glucuronide, and THCCOOH-glucuronide) polarity were employed with multiple reaction monitoring. Calibration by linear regression analysis utilized deuterium-labeled internal standards and a 1/x ² weighting factor, yielding R ² values >0.997 for all analytes. Linearity ranged from 0.5 to 50 μg/L (THC-glucuronide), 1.0–100 μg/L (THC, 11-OH-THC, THCCOOH, CBD, and CBN), and 5.0–250 μg/L (THCCOOH-glucuronide). Imprecision was <10.5% CV, recovery was >50.5%, and bias within ±13.1% of target for all analytes at three concentrations across the linear range. No carryover and endogenous or exogenous interferences were observed. This new analytical method should be useful for quantifying cannabinoids in whole blood and further investigating cannabinoid glucuronides as markers of recent cannabis intake.     

Simultaneous quantification of candesartan and irbesartan in rabbit eye tissues by liquid chromatography–tandem mass spectrometry

Diabetic retinopathy is a major cause of vision loss in adults. Novel eye-drop formulations of candesartan and irbesartan are being developed for its cure or treatment. To support a preclinical trial in rabbits, it was critical to develop and validate a new LC–MS/MS method for simultaneous quantification of candesartan and irbesartan in rabbit eye tissues (cornea, aqueous humor, vitreous body and retina/choroid). Eye tissue samples were first homogenized in H₂O-diluted rabbit plasma. The candesartan and irbesartan in the supernatants together with their respective internal standards (candesartan-d₄ and irbesartan-d₄) were extracted by solid-phase extraction. The extracted samples were injected onto a C₁₈ column for gradient separation. The MS detection was in the positive electrospray ionization mode using the multiple reaction monitoring transitions of m/z 441 → 263, 445 → 267, 429 → 207, and 433 → 211 for candesartan, candesartan-d₄, irbesartan and irbesartan-d₄, respectively. For the validated concentration ranges (2–2000 and 5–5000 ng/g for candesartan and irbesartan, respectively), the within-run and between-run accuracies (% bias) were within the range of −8.0–10.0. The percentage CV ranged from 0.6 to 7.3. There was no significant matrix interference nor matrix effect from different eye tissues and different rabbits. The validated method was successfully used in the Good Laboratory Practice (GLP) study of rabbits.     

Fractionation and characterization of gold nanoparticles in aqueous solution: asymmetric-flow field flow fractionation with MALS, DLS, and UV–Vis detection

Asymmetrical-flow field flow fractionation (AFFF) separates constituents based on hydrodynamic size and is emerging as a powerful tool for obtaining high-resolution information on the size, molecular weight, composition, and stability of nanoscale particles in liquid media. We employ a customized AFFF system combining on-line detectors for multi-angle light scattering, dynamic light scattering, and UV–Vis absorption. Our objective is to develop optimized measurement protocols for the characterization of gold nanoparticles (GNPs), which are widely utilized in biomedical research and other nanotechnology applications. Experimental conditions have been optimized by controlling key parameters, including injection volume and solids concentration, mobile phase composition, membrane type and pore size, and ratio of channel-to-cross-flow rates. Individual citrate-stabilized GNP components (nominally 10, 20, 30, 40, and 60 nm) and GNPs functionalized with polyethylene glycol were separated from multicomponent GNP mixtures by AFFF and subsequently characterized. We discuss the effects due to variations in measurement parameters and GNP surface modification on observed retention, recovery, and peak resolution.     

Modifier-assisted differential mobility–tandem mass spectrometry method for detection and quantification of amphetamine-type stimulants in urine

An advantage of differential mobility spectrometry (DMS) is it provides an orthogonal mechanism to mass spectrometry (MS). The DMS-MS/MS detects analytes in the gas phase on the basis of differences in ion mobility in low and high electric fields, which makes DMS-MS/MS an alternative to chromatographic separation-MS. One drawback of DMS is its limited resolution and sensitivity, especially for detecting small molecules when using a nonpolar inert gas as the carrier gas. The present work has evaluated the effects on peak capacity of adding chemical modifiers to inert carrier gases (nitrogen, helium, argon and carbon dioxide). Use of a methanol-helium mixture gave improvements in both separation and sensitivity. Nine structurally similar amphetamine-type stimulants were determined in urine without pretreatment of the samples before analysis. After optimization of carrier gas, nature and concentration of chemical modifier, and DMS temperature, limits of detection ranging from 1.1 to 2.7 ng mL⁻¹, with a linear range of three orders of magnitude (5–5000 ng mL⁻¹) were achieved. Precision was <15% and the accuracy of the quality control samples was 87.6–113.7%. For the quantitation of urine samples from drug abusers, data obtained using DMS-MS/MS showed reasonable agreement (within ±19.5%) with that obtained using LC-MS/MS. The analysis time for DMS-MS/MS was only 1.1 min and a paired sample t-test between the two methods gave a p-value of 0.0894, which indicates that DMS-MS/MS is a reliable method, with comparable precision and sensitivity to LC-MS/MS.